- Report
- February 2024
- 166 Pages
Global
From €2271EUR$2,500USD£1,960GBP
- Report
- January 2024
- 161 Pages
Global
From €2271EUR$2,500USD£1,960GBP
- Report
- December 2023
- 165 Pages
Global
From €2271EUR$2,500USD£1,960GBP
- Report
- June 2024
Global
From €4497EUR$4,950USD£3,881GBP
- Report
- December 2023
- 51 Pages
Global
From €4497EUR$4,950USD£3,881GBP
- Report
- March 2025
- 316 Pages
Global
From €4079EUR$4,490USD£3,520GBP
- Report
- March 2022
- 300 Pages
Global
From €4542EUR$5,000USD£3,920GBP
- Report
- March 2022
- 300 Pages
Global
From €4542EUR$5,000USD£3,920GBP
- Report
- March 2022
- 300 Pages
Global
From €4542EUR$5,000USD£3,920GBP
- Report
- March 2022
- 300 Pages
Global
From €3634EUR$4,000USD£3,136GBP
- Report
- March 2022
- 300 Pages
Global
From €4542EUR$5,000USD£3,920GBP
- Report
- August 2024
- 132 Pages
Global
From €2716EUR$2,990USD£2,344GBP
- Report
- April 2024
- 447 Pages
Global
From €3815EUR$4,200USD£3,293GBP
- Report
- February 2024
- 126 Pages
Global
From €2716EUR$2,990USD£2,344GBP
- Report
- February 2024
- 122 Pages
Global
From €2716EUR$2,990USD£2,344GBP
- Report
- December 2023
- 109 Pages
Global
From €2271EUR$2,500USD£1,960GBP
- Report
- February 2023
- 244 Pages
Global
From €3815EUR$4,200USD£3,293GBP
- Report
- November 2022
- 230 Pages
Global
From €3407EUR$3,750USD£2,940GBP
- Report
- October 2022
- 270 Pages
Global
From €3407EUR$3,750USD£2,940GBP
- Report
- September 2022
- 232 Pages
Global
From €3179EUR$3,500USD£2,744GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more